Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial
- DOI
- 10.1016/s2352-3026(26)00201-2
- Published
- 2026-09
- Container
- The Lancet Haematology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s2352-3026-26-00201-2,
title = {Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial},
author = {Alina Markova and Jelena Ostojić and Veronica Rotemberg and Ian Nykaza and Jad Kanbar and Esperanza B Papadopoulos and Stephen Dusza and Rizi Ai and Tara Maier and Mario E Lacouture and Roni Tamari and Brian C Shaffer and Michael Scordo and Miguel-Angel Perales and Andrew Harris and Doris M Ponce},
year = {2026},
journal = {The Lancet Haematology},
doi = {10.1016/s2352-3026(26)00201-2},
url = {https://doi.org/10.1016/s2352-3026(26)00201-2}
}RIS
TY - JOUR TI - Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial AU - Alina Markova AU - Jelena Ostojić AU - Veronica Rotemberg AU - Ian Nykaza AU - Jad Kanbar AU - Esperanza B Papadopoulos AU - Stephen Dusza AU - Rizi Ai AU - Tara Maier AU - Mario E Lacouture AU - Roni Tamari AU - Brian C Shaffer AU - Michael Scordo AU - Miguel-Angel Perales AU - Andrew Harris AU - Doris M Ponce PY - 2026 JO - The Lancet Haematology DO - 10.1016/s2352-3026(26)00201-2 UR - https://doi.org/10.1016/s2352-3026(26)00201-2 ER -
APA
Markova, A., Ostojić, J., Rotemberg, V., Nykaza, I., Kanbar, J., Papadopoulos, E. B., Dusza, S., Ai, R., Maier, T., Lacouture, M. E., Tamari, R., Shaffer, B. C., Scordo, M., Perales, M., Harris, A., & Ponce, D. M. (2026). Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial. The Lancet Haematology. https://doi.org/10.1016/s2352-3026(26)00201-2
Source records
- crossref · retrieved 2026-09-26T06:51:01.600Z